echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Gut | Watch out!

    Gut | Watch out!

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Proton pump inhibitors (PPIs) are one of the 10 most commonly used drugs in the world.


    PPIs are generally recommended for the treatment of diseases associated with hypersecretion of gastric acid, such as gastroesophageal reflux disease, medsci.


    Recent studies have shown that PPIs can affect the intestinal microbial community by changing the natural gastrointestinal environment.


    PPIs can affect the intestinal microbial community by changing the natural gastrointestinal environment.


    Type 2 diabetes (T2DM) has become a global epidemic, with a global prevalence rate of 8.


    The relationship between diabetes and "brain gut axis" and gut microbes

    The relationship between diabetes and "brain gut axis" and gut microbes

    In view of the significant impact of PPIs on the gut microbiota, its use may increase the risk of T2DM.


    In view of the significant impact of PPIs on the gut microbiota, its use may increase the risk of T2DM.


    A total of 204,689 non-diabetic participants participated in the Nurses’ Health Study (NHS), NHS Phase II, and Health Professional Follow-up Study (HPFS).


    diagnosis

    During the study period, more than 2127471 person-years of follow-up and 10105 diabetes events were recorded.


    Compared with people who use PPIs less often, participants who regularly take PPIs have a 24% higher risk of diabetes (HR=1.


    The duration of routine use of PPIs and the risk of T2DM.


    The duration of routine use of PPIs and the risk of T2DM.


    Even more surprising is that the risk of diabetes increases with the duration of the use of PPIs.


    It can be seen that the frequent use of PPIs is related to the high risk of T2DM, and the risk increases with the use of time.


    references:

    bmj.


    bmj.
    com/content/70/6/1070" target="_blank" rel="noopener">Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.